Global Head, Global Head, Business Development & Licensing NIBR (ad interim)
Novartis Institute of Biomedical Research, Cambridge (US)
Philip Gotwals is the Global Head, BD&L ad interim at Novartis Institutes for BioMedical Research (NIBR) where he oversees business development efforts for all disease areas and technology platforms. Previously, Phil was Executive Director, Exploratory Immuno-Oncology and instrumental in building NIBR’s immuno-oncology strategic research area including the CAR-T platform. He has more than 20 years of experience in the biotechnology and pharmaceutical industries, leading internal and collaborative R&D programs from drug discovery to new drug application filing, and leading the licensing of product candidates. Phil holds a Ph.D. in genetics from the University of California at Berkeley and completed postdoctoral research at the Massachusetts Institute of Technology.